Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948545 · ClinicalTrials.gov registry record
Autonomic Nervous System Function Following Bariatric Surgery
A clinical trial, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- 37
- Enrollment target
NCT00948545: Completed study, sponsored by Christiana Care Health Services.
NCT00948545 is a clinical trial that has completed, run by Christiana Care Health Services. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948545 has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
In the proposed study, the investigators will explore three specific aims. First, the investigators will examine cross-sectionally the association of obesity on sympathetic, parasympathetic, and sympathetic/ parasympathetic nerve fiber balance. In addition, the investigators will determine the relationship of the ANS and osteocalcin. Osteocalcin will be measured before and after a mixed meal tolerance test. In the second specific aim, the investigators will prospectively follow-up these individuals (n=30) following bariatric surgery. The effect of weight loss on measures of the ANS and osteocalcin will be examined 6 months following surgery with participants serving as their own control, pre- and post-surgical intervention. Thirdly, the investigators will address whether the effect of weight loss on the ANS and osteocalcin differ between those who had a history of diabetes at baseline versus those with no history of diabetes.
Interventions
- OTHER Observational study - there is no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-04 |
What the finished NCT00948545 record still lists
NCT00948545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational study - there is no intervention is the first listed.
NCT00948545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948545 about?
NCT00948545 is a clinical study titled "Autonomic Nervous System Function Following Bariatric Surgery". In the proposed study, the investigators will explore three specific aims. First, the investigators will examine cross-sectionally the association of obesity on sympathetic, parasympathetic, and sympathetic/ parasympathetic nerve fiber balance. In addition, the investigators will determine the relat...
What is the current status of trial NCT00948545?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2009-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00948545?
The interventions under investigation include: Observational study - there is no intervention (OTHER).
Who is sponsoring clinical trial NCT00948545?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia